Beyond its established roles in infections and inflammation (198), its efficacy relies on defined concentration thresholds, tumor-intrinsic factors (e.g., ubiquitin-like modifier activating enzyme 6 [UBA6] expression), and TME nutrient status. This evidence concerns the gene UBA6 and neoplasm.